Protalix BioTherapeutics
PLX
#8821
Rank
C$0.24 B
Marketcap
C$3.01
Share price
-0.90%
Change (1 day)
-14.87%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): C$0.02393

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is C$0.02733. In 2024 the company made an earnings per share (EPS) of C$0.05465 a decrease over its 2023 EPS that were of C$0.16.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$0.02393-56.22%
2024C$0.05465-66.67%
2023C$0.16-138.71%
2022C-$0.42-50%
2021C-$0.85181.82%
2020C-$0.30-82.11%
2019C-$1.68-31.67%
2018C-$2.46-72.31%
2017C-$8.88124.14%
2016C-$3.96-147.54%
2015C$8.33-290.63%
2014C-$4.376.67%
2013C-$4.10130.77%
2012C-$1.78-69.77%
2011C-$5.8819.44%
2010C-$4.92-12.2%
2009C-$5.6036.67%
2008C-$4.10-37.5%
2007C-$6.5650%
2006C-$4.373.23%
2005C-$4.24138.46%
2004C-$1.78-74%
2003C-$6.83-0%
2002C-$6.83-50%
2001C-$13.66233.33%
2000C-$4.10-84.21%
1999C-$25.96-24%
1998C-$34.16-600%
1997C$6.83-16.67%
1996C$8.20

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.86 6,700.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$6.59 24,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C-$0.15-650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$1.69 6,100.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel